Identification of (<i>R</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor

Devin M. Swanson(Janssen (United States)), Michael A. Letavic(Janssen (United States)), Xiahou Deng(Janssen (United States)), Brad M. Savall(Janssen (United States)), Anita Everson(Janssen (United States)), Nicholas I. Carruthers(Io Therapeutics (United States)), Kia Sepassi(Janssen (United States)), Hong Ao(Janssen (United States)), Anindya Bhattacharya(University of York), Meri De Angelis(Helmholtz Zentrum München), Jason C. Rech(Janssen (United States)), Brian Lord(Janssen (United States)), Freddy Schoetens(Janssen (United States)), Qi Wang(Hebei Medical University), Brian Scott(Janssen (United States)), Judith Skaptason(Janssen (United States)), Tatiana Koudriakova(Janssen (United States)), Kevin J. Coe(Janssen (United States)), Timothy W. Lovenberg(Janssen (Belgium)), Jessica L. Wall(Janssen (United States))
Journal of Medicinal Chemistry
August 22, 2016
Cited by 37


Related Papers